- Home
- POCI vs LTRN Comparison
POCI vs LTRN Comparison
Compare POCI & LTRN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- POCI
- LTRN
- Stock Information
- Founded
- POCI 1982
- LTRN 2013
- Country
- POCI United States
- LTRN United States
- Employees
- POCI N/A
- LTRN N/A
- Industry
- POCI Biotechnology: Electromedical & Electrotherapeutic Apparatus
- LTRN Biotechnology: Pharmaceutical Preparations
- Sector
- POCI Health Care
- LTRN Health Care
- Exchange
- POCI Nasdaq
- LTRN Nasdaq
- Market Cap
- POCI 32.3M
- LTRN 36.2M
- IPO Year
- POCI N/A
- LTRN 2020
- Fundamental
- Price
- POCI $5.11
- LTRN $3.48
- Analyst Decision
- POCI
- LTRN Hold
- Analyst Count
- POCI 0
- LTRN 1
- Target Price
- POCI N/A
- LTRN N/A
- AVG Volume (30 Days)
- POCI 12.7K
- LTRN 78.6K
- Earning Date
- POCI 02-12-2025
- LTRN 11-07-2024
- Dividend Yield
- POCI N/A
- LTRN N/A
- EPS Growth
- POCI N/A
- LTRN N/A
- EPS
- POCI N/A
- LTRN N/A
- Revenue
- POCI $18,980,148.00
- LTRN N/A
- Revenue This Year
- POCI N/A
- LTRN N/A
- Revenue Next Year
- POCI N/A
- LTRN N/A
- P/E Ratio
- POCI N/A
- LTRN N/A
- Revenue Growth
- POCI N/A
- LTRN N/A
- 52 Week Low
- POCI $3.47
- LTRN $2.79
- 52 Week High
- POCI $6.90
- LTRN $11.99
- Technical
- Relative Strength Index (RSI)
- POCI 50.35
- LTRN 47.65
- Support Level
- POCI $4.92
- LTRN $3.28
- Resistance Level
- POCI $5.48
- LTRN $4.88
- Average True Range (ATR)
- POCI 0.20
- LTRN 0.40
- MACD
- POCI -0.02
- LTRN -0.01
- Stochastic Oscillator
- POCI 28.36
- LTRN 15.91
About POCI Precision Optics Corporation Inc.
Precision Optics Corp Inc is engaged in designing, developing, and manufacturing advanced optical instruments. It manufactures medical products such as endoscopes and endocouplers which incorporate various optical technologies for use in a variety of minimally invasive surgical and diagnostic procedures. The company also produces endoscopes for various applications as well as designs and manufactures custom optical medical devices to satisfy customers' specific requirements. In addition, the company manufactures and sells components and assemblies specially designed for industrial and military use. The company earns the majority of its revenue from the United States.
About LTRN Lantern Pharma Inc.
Lantern Pharma Inc is an AI company transforming the cost, pace, and timeline of oncology drug discovery and development. Its proprietary AI and machine learning (ML) platform, RADR, uses oncology-focused data points and advanced ML algorithms to solve billion-dollar, real-world problems in cancer drug development. The group's growing pipeline of precision therapies has been accelerated using AI and input from world-class scientific advisors and collaborators.